Skip to main content

Table 1 Chemotherapy regimens, dosages, post-cooling times and number of patients who finished the DigniCap evaluation

From: Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling

Chemotherapy regimen and doses No of patients Post-cooling time (min)
(Neo-)adjuvant CT   
E90C600 (q3w*4) - > Doc100/175 (q3w*4)1 32 100
F500E100C500 (q3w*6) 15 120
F500E100C500 (q3w*3) - > Doc100 (q3w*3) 7 120 - > 100
E90C600 (q3w*4) 3 100
CarboPt/Doc (q3w*6) 1 90
Palliative CT   
Taxol135/Herceptin8mg/kg 1 90
Halaven1.23 1 120
Taxol90/Avastin10mg/kg 3 60
Carboplatin 1 90
Gemcitabine/Cisplatin (12) 60
  1. 1Three patients were included receiving three-weekly (neo-)adjuvant Doc/EC. Of them, one patient was treated with Doc175 and two with Doc100.
  2. 2One patient finished an adjuvant CT (EC/Doc) before a palliative treatment (three cycles Carboplatin followed by two cycles Gemcitabine/Cisplatin) was started.